Intrexon Corp. (XON)

Company Description

Intrexon Corporation, founded in 1998, is a biotechnology company focused on collaborating with companies in Health, Food, Energy, and Environment to create biologically based products that improve quality of life and the health of the planet. At present rates of global industrialization and population growth, food and energy supplies and environmental and healthcare resources are becoming scarcer. We believe Intrexon’s leading Better DNA™ approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges.

With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Working with key collaborators, Intrexon seeks to develop high value applications that can bring better medicines to more people, alleviate shortages of essential nutrients, develop renewable fuels and other resources, and protect the environment..

COMPANY ADDRESS
0374 Seneca Meadows Parkway
Germantown, Maryland 20876
United States

COMPANY PHONE
301-556-9900

COMPANY WEBSITE



Get BioInvest's perspective on Intrexon's CEO


Latest Company News

Intrexon Corporation (NYSE:XON) Valuation in the Spotlight Business Review - 2 hours ago Intrexon Corporation (NYSE:XON) has an ERP5 rank of 15984. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. [...]
Fri, Mar 24, 2017 11:37:00 PM, Continue reading at the source
Analyst Recommendations And Earnings Forecast: Intrexon Corporation (XON ... Post Analyst - 7 hours ago Over the last five days, shares have faced -11.46% losses and now is down -26.88% since hitting its 200-day moving average of $25.77. [...]
Fri, Mar 24, 2017 6:00:00 PM, Continue reading at the source
Stock Returns: Advanced Accelerator Applications SA (NASDAQ:AAAP) is Beating ... CML News - 10 hours ago This is a snapshot to compare the stock returns for Advanced Accelerator Applications S.A. (NASDAQ:AAAP) versus Intrexon Corporation (NYSE:XON) . The stock return points we compare look at the last three-months, six-months and twelve-months. [...]
Fri, Mar 24, 2017 3:00:00 PM, Continue reading at the source
Intrexon Corp (XON) Receives Average Recommendation of “Buy” from Analysts Chaffey Breeze - Mar 22, 2017 Intrexon Corp logo Shares of Intrexon Corp (NYSE:XON) have been given a consensus recommendation of “Buy” by the eight brokerages that are covering the firm. Wall Street Stories: Intrexon Corporation (NYSE:XON), The Goldman Sachs Group ... - Benchmark Monitor What are Analyst's Indicators for Intrexon Corporation (XON), United Rentals ... - The USA Commerce [...]
Wed, Mar 22, 2017 6:56:00 PM, Continue reading at the source
The Intrexon Corp (XON) Price Target Cut to $35.00 Petro Global News 24 - Mar 19, 2017 Intrexon Corp (NYSE:XON) had its target price trimmed by Wunderlich from $50.00 to $35.00 in a research report sent to investors on Tuesday morning. Intrexon Corp (XON) Stake Lowered by State Street Corp - Chaffey Breeze Intrexon Corp (NYSE:XON)'s subsidiary announced the appointment of General Manager - Benchmark Monitor [...]
Sun, Mar 19, 2017 9:45:00 AM, Continue reading at the source
The Intrexon Corp (XON) Trading Down 8.9% on Analyst Downgrade Petro Global News 24 - Mar 16, 2017 Shares of Intrexon Corp (NYSE:XON) fell 8.9% on Tuesday after Wunderlich lowered their price target on the stock from $50.00 to $35.00. JMP Securities Initiates Coverage on the shares of Intrexon Corporation (XON ... - HugoPress Wunderlich Trims Intrexon Corp (XON) Target Price to $35.00 - Sports Perspectives [...]
Thu, Mar 16, 2017 5:37:00 AM, Continue reading at the source
Former Pfizer Inc. (NYSE:PFE) Executive Leaves Intrexon Corp (NYSE:XON) Less ... Journal Transcript - Mar 16, 2017 Less than a year after joining Intrexon Corp (NYSE:XON) from Pfizer Inc. (NYSE:PFE), Geno Germano is leaving the company after a reorganization that saw the programs he was heading stripped away and handed to a new entity. Analyst Activity – Wunderlich Lowers Its Price Target On Intrexon Corp (NYSE ... - Market Exclusive Wunderlich Lowers Intrexon Corp (XON) Price Target to $35.00 - Chaffey Breeze [...]
Thu, Mar 16, 2017 4:52:00 AM, Continue reading at the source
Intrexon Corp to Post FY2021 Earnings of $1.91 Per Share, Griffin Securities ... Chaffey Breeze - Mar 11, 2017 Intrexon Corp logo Intrexon Corp (NYSE:XON) - Equities researchers at Griffin Securities issued their FY2021 earnings per share (EPS) estimates for Intrexon Corp in a research note issued on Wednesday. Griffin Securities analyst K. Markey anticipates ... FY2021 Earnings Estimate for Intrexon Corp (XON) Issued By Griffin Securities - The Cerbat Gem INTREXON CORPORATION (NYSE:XON) Files An 8-K Departure of Directors or Certain ... - Market Exclusive [...]
Sat, Mar 11, 2017 2:48:00 PM, Continue reading at the source
INTREXON CORPORATION (NYSE:XON) Files An 8-K Results of Operations and ... Market Exclusive - Mar 1, 2017 Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. Intrexon's (XON) CEO Randal Kirk on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha Analyst's Indicator Review for Intrexon Corporation (XON), CF Industries ... - The USA Commerce [...]
Wed, Mar 01, 2017 11:37:00 PM, Continue reading at the source
Vandana Sinha Managing Editor Washington Business Journal Washington Business Journal - Jan 24, 2017 Germantown-based Intrexon Corp. is swallowing up its fellow Montgomery County biotech, GenVec Inc., a small Gaithersburg gene therapy company that has been struggling to grow since its lead cancer drug candidate failed in late-stage trials in 2010. Intrexon to acquire GenVec in all-stock deal - Seeking Alpha Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform - PR Newswire (press release) [...]
Tue, Jan 24, 2017 5:35:00 PM, Continue reading at the source